CULVERHAY SURGERY — All Prescriptions & Medications — Page 8
Practice Code: L84027 | WOTTON UNDER EDGE, GL12 7LS
Showing results 351-400 of 688
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Lisdexamfetamine dimesylate | 91 | 2,688 | £6.9K | -23.8% ▼ |
| 91 | 1,394 | £4.3K | +667.5% ▲ | |
| Fenofibrate | 89 | 3,164 | £348 | -8.0% ▼ |
| 88 | 11.0K | £20.7K | +80.6% ▲ | |
| 87 | 4,290 | £9.0K | +514.8% ▲ | |
| Levonorgestrel | 86 | 88 | £6.8K | +127.9% ▲ |
| Mycophenolate mofetil | 86 | 7,280 | £818 | +112.4% ▲ |
| Ketoconazole | 86 | 10.9K | £1.1K | -12.4% ▼ |
| Fluvastatin sodium | 85 | 2,408 | £809 | +267.5% ▲ |
| 85 | 774 | £886 | +159.1% ▲ | |
| 85 | 285 | £65 | +138.4% ▲ | |
| Ferrous gluconate | 84 | 5,113 | £146 | +75.6% ▲ |
| Brimonidine tartrate | 83 | 635 | £288 | +107.9% ▲ |
| Adapalene and benzoyl peroxide | 79 | 3,600 | £1.5K | +47.9% ▲ |
| Powder thickener - gum based (0913161) | 77 | 24.9K | £1.4K | +2.5% ▲ |
| Metronidazole | 77 | 2,560 | £768 | +104.9% ▲ |
| 77 | 1,291 | £2.2K | +1,307.5% ▲ | |
| 77 | 14.0K | £401 | +54.3% ▲ | |
| 77 | 5,010 | £17.1K | +104.9% ▲ | |
| 77 | 4,580 | £6.2K | +371.8% ▲ | |
| Hyoscine hydrobromide | 76 | 2,265 | £367 | +122.6% ▲ |
| Denosumab | 76 | 76 | £14.1K | +179.3% ▲ |
| 76 | 192 | £968 | +145.0% ▲ | |
| Hydralazine hydrochloride | 75 | 5,680 | £315 | +77.7% ▲ |
| Glycerol | 74 | 1,980 | £327 | +110.9% ▲ |
| Sodium chloride | 74 | 6,781 | £4.4K | +148.8% ▲ |
| 74 | 74 | £81 | +179.9% ▲ | |
| 74 | 6,199 | £11.9K | +85.5% ▲ | |
| Hydroxycarbamide | 73 | 5,524 | £797 | +153.1% ▲ |
| 72 | 516 | £3.8K | +309.8% ▲ | |
| Desloratadine | 71 | 2,430 | £226 | +146.2% ▲ |
| Levocetirizine | 71 | 796 | £112 | +355.6% ▲ |
| 71 | 415 | £1.2K | +659.1% ▲ | |
| Azelaic acid | 70 | 2,250 | £483 | +192.8% ▲ |
| Ondansetron hydrochloride | 69 | 2,034 | £878 | +42.2% ▲ |
| Mefenamic acid | 69 | 2,848 | £559 | +52.7% ▲ |
| Olmesartan medoxomil | 68 | 2,492 | £104 | -1.3% vs avg |
| Estradiol valerate | 67 | 1,344 | £111 | +243.1% ▲ |
| Duloxetine hydrochloride | 67 | 3,017 | £654 | +30.7% ▲ |
| Leflunomide | 66 | 1,980 | £123 | +74.4% ▲ |
| Rasagiline mesilate | 65 | 1,820 | £1.1K | +75.0% ▲ |
| Trihexyphenidyl hydrochloride | 65 | 7,050 | £1.8K | +129.2% ▲ |
| 65 | 2,150 | £13.1K | +408.8% ▲ | |
| Carmellose sodium | 64 | 4,380 | £619 | -1.2% vs avg |
| Lacosamide | 63 | 3,976 | £2.1K | +17.2% ▲ |
| Celecoxib | 63 | 3,780 | £169 | -4.6% ▼ |
| 63 | 6,330 | £1.4K | +144.3% ▲ | |
| 63 | 5,690 | £729 | +181.7% ▲ | |
| Budesonide | 62 | 2,532 | £2.0K | +295.7% ▲ |
| Terbutaline sulphate | 62 | 102 | £508 | +14.3% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.